http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CU-24345-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116fa4406381fc82bb76e8657e68788a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dc1e0632340c52db52dfedc5488325c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65e6ac8c9c056586f63e8e785955bca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_189eddd1100625ffa30072369d8b872b
publicationDate 2018-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CU-24345-B1
titleOfInvention DERIVATIVES OF 1,3,4-OXADIAZOL AND 1,3,4-TIADIAZOL AS IMMUNOMODULATORS
abstract <p> The present invention relates to 1,3,4-oxadiazole and 1,3,4-thiadiazole compounds as therapeutic agents capable of inhibiting the signaling pathway of programmed cell death 1 (PD1). The invention also relates to derivatives of therapeutic agents. The invention further encompasses the use of said therapeutic agents and derivatives for the treatment of disorders through immunopotentiation comprising the inhibition of the immunosuppressive signal induced due to PD-1, PD-L1 or PD-L2 and the therapies where they are used. . </p>
priorityDate 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID80380
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415800927
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613842
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29126
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5133
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58205
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97428

Total number of triples: 33.